Melanoma trials in China

In China 69 Also abroad 579

69 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Where
Beijing, Chongqing, Guangzhou, Shanghai, Xinxiang
Age
18 years and over
People
254 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07492680
Phase 4Taking people
Dabrafenib and/or Trametinib Rollover Study
Where
Beijing
Age
18 years to 100 years
People
100 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00
Phase 1/2Not yet taking people in China
Combination Immunotherapy Targeting Melanoma
Where
Shenzhen
Age
18 years to 75 years
People
30
Run by
Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT06739226
Phase 2Taking people
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Where
Beijing, Changsha, Chengdu, Dongguan, Henan, Hubei, Shanghai, Shenyang, Wuhan, Xi'an, Xinxiang, Xuzhou
Age
18 years and over
People
750 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00
Phase 1/2Taking people
A Study of BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors
Where
Beijing
Age
18 years to 75 years
People
30
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07841925
Phase 2Taking people
HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma（FASTIL-Mela02）
Where
Beijing
Age
18 years to 75 years
People
90
Run by
Hangzhou Huasai Biomedicine Co., Ltd.
See details and how to joinNCT07406724
Phase 2Taking people
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Where
Chengdu, Guangzhou
Age
18 years and over
People
740 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00
Phase 1/2Taking people
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Where
Baoding, Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Ganzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Linyi, Luoyang, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Taizhou, Tianjin, Wuhan, Xi’an, Xinxiang, Zhengzhou
Age
18 years and over
People
862 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT05914116
Phase 1/2Taking people
A Trial of LBL-024 Monotherapy or Combination With Toripalimab in Patients With Advanced Melanoma.
Where
Beijing, Changchun, Chengdu, Fuzhou, Guangzhou, Hangzhou, Jinan, Kunming, Nanjing, Nanning, Shanghai, Taiyuan, Tianjin, Wuhan, Xi'an
Age
18 years and over
People
280
Run by
Nanjing Leads Biolabs Co.,Ltd
See details and how to joinNCT07099430
No phaseTaking people
68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
Where
Beijing
Age
18 years and over
People
50
Run by
Peking University Third Hospital
See details and how to joinNCT07760012
Phase 1Taking people
Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors
Where
Beijing
Age
18 years and over
People
167
Run by
Shandong Boan Biotechnology Co., Ltd
See details and how to joinNCT06596915
Phase 1/2Taking people
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Where
Chongqing, Hangzhou, Tianjin, Wuhan
Age
18 years and over
People
1,438 worldwide
Run by
BioNTech SE
See details and how to joinNCT07070232 · EU 2024-517261-16-00
Phase 2Taking people
Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab (QL1706), Intravenous Dacarbazine, and Oral Lenvatinib in Patients With Liver Metastases From Malignant Melanoma: a Single-arm, Phase II, Prospective Trial
Where
Guangzhou
Age
18 years to 75 years
People
28
Run by
Sun Yat-sen University
See details and how to joinNCT07847359
Phase 2Taking people
Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes
Where
Beijing
Age
18 years and over
People
50
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT07848243
Phase 1Taking people
A Study of DXC014 in Patients With Advanced Solid Tumors.
Where
Beijing, Changsha, Hangzhou, Nanchang, Qingdao
Age
18 years and over
People
150
Run by
Hangzhou DAC Biotechnology Co., Ltd.
See details and how to joinNCT07177937
Phase 1Taking people
Au-TMP and Radiotherapy for Advanced Melanoma With Anti-PD-1 Therapy
Where
Chengdu
Age
18 years and over
People
6
Run by
West China Hospital
See details and how to joinNCT07562841
Phase 2Taking people
Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery
Where
Changchun
Age
18 years and over
People
220
Run by
The First Hospital of Jilin University
See details and how to joinNCT07400302
Phase 1Taking people
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Where
Beijing, Haerbin, Linyi, Shanghai
Age
18 years and over
People
400 worldwide
Run by
Pierre Fabre Medicament
See details and how to joinNCT04913285
Phase 2Taking people
A Phase II Trial of LM103 in Advanced Melanoma
Where
Beijing, Changchun, Chengdu, Fuzhou, Guangzhou, Hangzhou, Nanjing, Nanning, Shanghai, Tianjin, Wuhan, Xi'an, Zhengzhou
Age
18 years to 75 years
People
92
Run by
Suzhou BlueHorse Therapeutics Co., Ltd.
See details and how to joinNCT07310784
Phase 1/2Taking people
Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma and Urinary Tract Tumors
Where
Beijing
Age
18 years and over
People
500
Run by
Shanghai JMT-Bio Inc.
See details and how to joinNCT07280832
Phase 2Taking people
Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma
Where
Guangzhou
Age
18 years and over
People
37
Run by
Sun Yat-sen University
See details and how to joinNCT07750067
Phase 1/2Taking people
A Clinical Study of T3011 in Subjects With Advanced Melanoma
Where
Beijing, Bengbu, Changchun, Chengdu, Fuzhou, Zhengzhou, Zhongshan
Age
18 years and over
People
42
Run by
Shanghai Pharmaceuticals Holding Co., Ltd
See details and how to joinNCT06214156
Phase 2Taking people
A Study of GC101 TIL in Advanced Melanoma
Where
Beijing
Age
18 years to 75 years
People
98
Run by
Shanghai Juncell Therapeutics
See details and how to joinNCT06703398
Phase 2Taking people
A Study of IBI363 in Subjects With Advanced Melanoma
Where
Beijing, Changchun, Changsha, Fuzhou, Jinan, Kunming, Nanchang, Nanjing, Taiyuan, Zhengzhou
Age
18 years and over
People
180
Run by
Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT06081920
Phase 1Taking people
A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
Where
Fuzhou, Hangzhou, Luoyang, Tianjin, Wenzhou, Wuhan, Xi'an
Age
18 years to 70 years
People
174
Run by
Shanghai Henlius Biotech
See details and how to joinNCT07518043